IP Cases — 2025
5,670 decisions across all jurisdictions
Page 113 of 189 · 5,670 total
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple (as petitioner) prevailed in IPR2020‑00175, with the PTAB finding all challenged claims of the ’299 wearable physiological‑monitoring patent unpatentable as obvious over Lisogurski, Carlson, Mannheimer and Park references.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple has filed an IPR petition seeking to invalidate Omni MedSci’s ’484 wearable health‑monitoring patent. The petition asserts that the claims are obvious over a suite of prior‑art references covering optical sensing, AI processing and cloud connectivity. Apple requests that the Board institute the trial and find all claims unpatentable.
Samsung Electronics Co., Ltd. et al. v.Radian Memory Systems LLC
Samsung and Radian have reached a confidential settlement and jointly moved to terminate the inter partes review of U.S. Patent 11,347,657, arguing that the proceeding is at an early stage and termination serves public policy and efficiency.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple (as petitioner) seeks to invalidate Omni MedSci’s ’533 wearable health‑monitoring patent, asserting that the claims are obvious over Lisogurski, Carlson, and Mannheimer. The petition requests the PTAB to institute an IPR and cancel the claims.
Microsoft Corporation v.Dialect, LLC
A statistical study of 192 IPR final written decisions from 2021 shows that patents invalidated in IPR have far more prior‑art citations and often depend on new evidence such as expert testimony. The findings suggest that post‑grant challenges frequently introduce prior art outside the examiner’s original search scope.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s IPR petition challenges Omni MedSci’s ’484 wearable health‑monitoring patent, asserting that all 23 claims are obvious over a combination of prior‑art references. The petition seeks institution and a finding of unpatentability.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Samsung and Apple have filed an IPR petition challenging Omni MedSci’s ’533 patent covering wearable optical health monitors. The petition asserts obviousness over Lisogurski, Carlson, and Mannheimer references and asks the Board to institute the review and cancel the claims.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple has filed an IPR petition seeking to invalidate Omni MedSci’s ’484 wearable health‑monitoring patent. The petition argues the claims are obvious over a combination of five prior‑art references and requests that the Board institute the trial.
Microsoft Corporation v.Dialect, LLC
Microsoft and Dialect reached a confidential settlement, leading the PTAB to terminate the IPR before trial. The Board granted the joint motion and ordered the settlement to remain confidential.
Microsoft Corporation v.Dialect, LLC
Microsoft and Dialect reached a settlement that resolves disputes over patent 8,620,659 and other patents, leading to a joint motion to terminate the inter partes review before the Board makes an institution decision.
Microsoft Corporation v.Dialect, LLC
Microsoft and Dialect have jointly moved to keep their settlement agreement confidential, invoking trade‑secret protections under the CFR. The motion seeks Board‑only access and notification of any disclosure requests.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple seeks to invalidate Omni MedSci’s wearable health‑monitor patent, arguing that all challenged claims are obvious over prior art. The petition requests the PTAB to institute an IPR and cancel the claims.
Microsoft Corporation v.Dialect, LLC
The PTAB denied Microsoft’s petition for an inter partes review of five patents owned by Dialect, LLC, exercising discretion under 35 U.S.C. § 314(a). The Board cited the patents’ age, subsidiary ownership, and a parallel district court case as reasons to avoid duplication.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple (as petitioner) prevailed on 12 of the 23 challenged claims of Omni MedSci’s wearable physiological monitoring patent, finding them obvious over multiple prior‑art references. The remaining claims were left unpatentable pending further proof.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
The PTAB held that Apple’s wearable physiological measurement claims were obvious over prior‑art pulse‑oximetry references, rendering all challenged claims unpatentable. The decision relied on Lisogurski, Carlson, and Mannheimer teachings.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s IPR resulted in the Board finding all six challenged claims of Omni MedSci’s ’299 patent unpatentable as obvious over a combination of prior‑art references covering wearable optical sensing.
Samsung Electronics Co., Ltd. et al. v.Radian Memory Systems LLC
Samsung Electronics and Radian Memory Systems settled their IPR dispute over patent 11307995 before trial. The Board granted the joint motion to terminate, ending the proceedings.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
The PTAB issued a Final Written Decision in IPR2021‑00453, finding claims 1,2,7 and 15‑23 of Omni MedSci’s wearable pulse‑oximeter patent unpatentable over prior art, while leaving the remaining claims intact.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s IPR against Omni MedSci’s wearable physiological measurement patent resulted in all challenged claims being held unpatentable. The Board found the claims obvious over Lisogurski, Carlson, and Mannheimer under §103(a).
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s inter‑partes review of Omni MedSci’s ’533 patent resulted in the PTAB finding all challenged claims unpatentable for obviousness over Lisogurski, Carlson, and Mannheimer.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple won a PTAB IPR against Omni MedSci, finding 12 of the 23 challenged claims of the 10,517,484 B2 wearable health‑monitoring patent unpatentable, while the remaining claims survived.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s IPR against Omni MedSci’s wearable health‑monitoring patent resulted in the Board finding all challenged claims unpatentable as obvious over a combination of prior‑art references.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple (as petitioner) secured a Final Written Decision finding claims 1,2,7,15‑23 of Omni MedSci’s wearable health‑monitoring patent unpatentable as obvious over prior‑art. The Board affirmed the petitioner's obviousness arguments while leaving claims 3‑6 and 8‑14 intact.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s petition succeeded; the PTAB held all challenged claims of Omni MedSci’s wearable physiological measurement patent unpatentable as obvious over Lisogurski, Carlson, and Mannheimer references.
Samsung Electronics Co., Ltd. et al. v.Radian Memory Systems LLC
Samsung and Radian Memory Systems settled their IPR dispute over patent 11,347,656 before trial, leading the Board to terminate the proceedings.
Samsung Electronics Co., Ltd. et al. v.Radian Memory Systems LLC
Samsung and Radian have filed a joint motion to terminate IPR2025-01376 under 35 U.S.C. § 317(a) after reaching a confidential settlement. The Board has not yet issued an institution decision.
Samsung Electronics Co., Ltd. et al. v.Radian Memory Systems LLC
Samsung Electronics and Radian Memory Systems settled their IPR dispute (IPR2025-01378) before trial. The Board granted the joint motion to terminate and kept the settlement documents confidential.
Samsung Electronics Co., Ltd. et al. v.Radian Memory Systems LLC
Samsung and Radian Memory Systems have reached a confidential settlement and jointly moved to terminate the inter partes review of U.S. Patent 11,347,656. The Board is asked to dismiss the proceeding under 35 U.S.C. § 317(a).
Regions Bank v.United Services Automobile Association
Regions Bank and USAA jointly moved to keep their IPR settlement agreement confidential under 35 U.S.C. § 317(b) and related regulations.
Regions Bank v.United Services Automobile Association
Regions Bank and United Services Automobile Association have settled their dispute over U.S. Patent No. 12,211,095 and jointly moved to terminate the inter partes review. The Board is asked to dismiss the proceeding under §317(a) before any merits are decided.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.